This webinar will share information on the influence of multimillion-dollar pharmaceutical costs, along with successful cost containment practices demonstrated through case studies of effective intervention.
A federal judge dismissed a challenge by hospital groups to a federal rule requiring them to disclose prices they quietly negotiate with insurers, in a victory for White House efforts to make healthcare pricing more transparent to patients.
MJH Life Sciences officially launched Medical World News, a first-of-its-kind 24-hour news program offering insights on the latest news in health care.
Governments around the world have spent $10 trillion in fiscal actions to respond to the novel coronavirus pandemic and its economic fallout, but significant further efforts are needed, the head of the International Monetary Fund said.
Concentric Health Experience has created the first podcast in a regular series known as “No Citations” that is is focused on the shifting healthcare marketing space.
Substantial activity from the novel coronavirus combined with a major flu season this fall could place a tremendous burden on the healthcare system, a top U.S. health official said.
Businesses, professional bodies and individual practitioners have to keep talking at a time like this, not least because patients’ non-Covid-related needs have not disappeared overnight. How are lines of communication holding up, and what might this tell us about life after Covid-19?
Data analytics group GlobalData released a report that showed the global health care sector has been subjected to an array of cyberattacks as the industry deals with the COVID-19 pandemic.
The MIT COVID-19 Challenge was a 48-hour virtual event that hosted 1,500 hackers and created 238 teams to address COVID-19 challenges within 10 focus tracks.
In a competitive market, brands rely on their reputations to give them an edge. However, these reputations are built on perceptions — and because it’s up to consumers to develop their own perceptions, brands may feel as though they have less control in developing lasting loyalty. This is especially true in the pharmaceutical industry due to where pharmaceutical manufacturers reside within healthcare’s value chain. In the patient-doctor relationship, pharmaceutical companies are the left-out third wheel.
